Cargando…
Sodium-Glucose Cotransporter 2 Inhibitors Mechanisms of Action: A Review
Sodium-Glucose Cotransporter 2 inhibitors (SGLT2i), or gliflozins, are a group of antidiabetic drugs that have shown improvement in renal and cardiovascular outcomes in patients with kidney disease, with and without diabetes. In this review, we will describe the different proposed mechanisms of acti...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8720766/ https://www.ncbi.nlm.nih.gov/pubmed/34988095 http://dx.doi.org/10.3389/fmed.2021.777861 |